SARS-CoV-2 IgA and IgG in Human Milk of Women Infected During Pregnancy
Main Article Content
Abstract
Background:
SARS-CoV-2 infection is still ongoing worldwide. The passage of SARS-CoV-2 antibodies through human milk provides essential protection to infants. The objective of this study was to determine the presence of immunoglobulins in the human milk at 2 and 6 weeks post-delivery of women who tested positive for the SARS-CoV-2 virus during pregnancy.
Methods:
This prospective observational cohort study was conducted between April 2020 and January 2021. We collected human milk from mothers who tested positive for the SARS-CoV-2 virus during pregnancy. Human milk IgG and IgA antibodies against SARS-CoV-2 S1 RBD protein were measured.
Results:
Eighty-one human milk samples were collected from 57 mothers infected during pregnancy. Human milk collected at 2 weeks post-delivery was positive for SARS-CoV-2 IgG in 82% and IgA in 49% of samples. At 6 weeks, human milk was positive for SARS-CoV-2 IgG in 67% and for IgA in 37% of samples. There was no correlation between the IgG or IgA levels at 2 weeks post-delivery and days from the first positive PCR test to delivery or gestational age at the first positive PCR test. SARS-CoV-2 antibodies were detectable in human milk of mothers who were PCR positive early in gestation. There was no significant difference in human milk IgG or IgA levels when comparing maternal symptom severity. The IgA and IgG levels were lower at 6 weeks compared to 2 weeks in 79% of the paired samples.
Conclusions:
Human milk of mothers infected with the SARS-CoV-2 virus during pregnancy showed the presence of both IgG and IgA against the virus protein. Continued human milk feeding of infants born to mothers infected with SARS-CoV-2 should be encouraged to optimize protective antibodies transferred to the infant.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Oddy WH. The impact of breastmilk on infant and child health. Breastfeed Rev. Nov 2002; 10(3):5-18.
3. Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. Mar 18 2021;184(6): 1486-1499. doi:10.1016/j.cell.2021.02.031
4. Song D, Prahl M, Gaw SL, et al. Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort study. medRxiv. May 03 2021; doi:10.1101/2021.05.01.21255871
5. WHO. Clinical management of COVID-19: Interim guidance, 27 May 2020. World Health Organization. Accessed November 7, 2022. https://creativecommons.org/licenses/by-nc-sa/3.0/igo
6. Kumar J, Meena J, Yadav A, Kumar P. SARS-CoV-2 detection in human milk: a systematic review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. Feb 08 2021:1-8. doi:10.1080/14767058.2021.1882984
7. Centeno-Tablante E, Medina-Rivera M, Finkelstein JL, et al. Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review. Ann N Y Acad Sci. 01 2021;1484 (1):32-54. doi:10.1111/nyas.14477
8. Krogstad P, Contreras D, Ng H, et al. No Evidence of Infectious SARS-CoV-2 in Human Milk: Analysis of a Cohort of 110 Lactating Women. medRxiv. Apr 07 2021; doi:10.1101/2021.04.05.21254897
9. Pace RM, Williams JE, Järvinen KM, et al. COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity. medRxiv. Sep 18 2020; doi:10.1101/2020.09.16.20196071
10. Gao X, Wang S, Zeng W, et al. Clinical and immunologic features among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes New Infect. Sep 2020;37:100752.
doi:10.1016/j.nmni.2020.100752
11. Dong Y, Chi X, Hai H, et al. Antibodies in the breast milk of a maternal woman with COVID-19. Emerg Microbes Infect. Dec 2020;9(1):1467-1469. doi:10.1080/22221751.2020.1780952
12. Lebrão CW, Cruz MN, Silva MHD, et al. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection. J Hum Lact. Nov 2020;36(4):609-613. doi:10.1177/0890334420960433
13. Fox A, Marino J, Amanat F, et al. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. iScience. Nov 20 2020; 23(11):101735. doi:10.1016/j.isci.2020.101735
14. Pace RM, Williams JE, Järvinen KM, et al. Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19. mBio. 02 09 2021;12(1) doi:10.1128/mBio.03192-20
15. Halscott TM, MS, Vaught JM, Miller EM, MPH. Management Considerations for Pregnant Patients with Covid-19. Society for Maternal Fetal Medicine High Risk Pregnancy Experts; 2020. Accessed November 7, 2022.
https://www.smfm.org/covidclinical
16. Szczygiol P, Lukianowski B, Koscielska-Kasprzak K, et al. Antibodies in the breastmilk of COVID-19 recovered women. BMC Pregnancy Childbirth. Aug 11 2022;22(1):635. doi:10.1186/s12884-022-04945-z
17. Young BE, Seppo AE, Diaz N, et al. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination. JAMA Pediatr. 02 01 2022;176(2):159-168.
doi:10.1001/jamapediatrics.2021.4897
18. Duncombe CJ, McCulloch DJ, Shuey KD, et al. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection. J Clin Virol. 09 2021;142:104916. doi:10.1016/j.jcv.2021.104916
19. Cabanillas-Bernal O, Cervantes-Luevano K, Flores-Acosta GI, Bernáldez-Sarabia J, Licea-Navarro AF. COVID-19 Neutralizing Antibodies in Breast Milk of Mothers Vaccinated with Three Different Vaccines in Mexico. Vaccines (Basel). Apr 18 2022;10(4)doi:10.3390/vaccines10040629
20. Bauerl C, Randazzo W, Sanchez G, et al. SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain. Archives of disease in childhood Fetal and neonatal edition. Mar 2022;107(2):216-221. doi:10.1136/archdischild-2021-322463
21. Wachman EM, Snyder-Cappione J, Devera J, et al. Maternal, Infant, and Breast Milk Antibody Response Following COVID-19 Infection in Early Versus Late Gestation. Pediatr Infect Dis J. Mar 1 2023;42(3):e70-e76. doi:10.1097/INF.0000000000003802
22. Jakuszko K, Kościelska-Kasprzak K, Żabińska M, et al. Immune Response to Vaccination against COVID-19 in Breastfeeding Health Workers. Vaccines (Basel). Jun 17 2021;9(6) doi:10.3390/vaccines9060663
23. Golan Y, Prahl M, Cassidy AG, et al. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads. Front Immunol. 2021;12:77 7103. doi:10.3389/fimmu.2021.777103
24. Kelly JC, Carter EB, Raghuraman N, et al. Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination. Am J Obstet Gynecol. Jul 2021;225(1):101-103. doi:10.1016/j.ajog.2021.03.031
25. Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. JAMA. May 18 2021;325(19):2013-2014. doi:10.1001/jama.2021.5782
26. Rosenberg-Friedman M, Kigel A, Bahar Y, et al. BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women. Nat Commun. Oct 28 2021;12(1):6222. doi:10.1038/s41467-021-26507-1
27. Gray KJ, Bordt EA, Atyeo C, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. Sep 2021;225(3):303 e1-303 e17. doi:10.1016/j.ajog.2021.03.023
28. Lechosa-Muniz C, Paz-Zulueta M, Mendez-Legaza JM, et al. Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain. Int J Environ Res Public Health. Aug 21 2021;18(16) doi:10.3390/ijerph18168831
29. Selma-Royo M, Bauerl C, Mena-Tudela D, et al. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study. Genome Med. Apr 21 2022;14(1):42. doi:10.1186/s13073-022-01043-9
30. Total Covid-19 Vaccine doses administered per 100 people. Our World in Data. Updated August 14, 2024. Accessed September 11, 2024. https://ourworldindata.org/grapher/covid-vaccination-doses-per-capita?tab=map&time=latest
31. Covid-19 Vaccination Coverage and Vaccine Confidence Among Adults. Accessed September 11, 2024. https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/adults.html